{
  "url": "https://openlegislation.uk/human-medicines-regulations-2012/schedule-13/paragraph-wrapper3n1",
  "json_url": "https://openlegislation.uk/human-medicines-regulations-2012/schedule-13/paragraph-wrapper3n1.json",
  "legislation": "uksi/2012/1916",
  "legislation_title": "The Human Medicines Regulations 2012",
  "legislation_url": "https://openlegislation.uk/human-medicines-regulations-2012",
  "path": "schedule/13/paragraph/wrapper3n1",
  "kind": "paragraph",
  "number": null,
  "heading": null,
  "text": "Co-danthramer Capsules NPF\nCo-danthramer Capsules Strong NPF\nCo-danthramer Oral Suspension NPF\nCo-danthramer Oral Suspension Strong NPF\nCo-danthrusate Capsules\nCo-danthrusate Oral Suspension NPF\nMebendazole Tablets NPF\nMebendazole Oral Suspension NPF\nMiconazole Oral Gel NPF\nNystatin Oral Suspension\nNystatin Pastilles NPF\nStreptokinase and Streptodornase Topical Powder NPF\nWater for injections\nIn this Schedule “NPF” means the Nurse Prescribers' Formulary Appendix in the British National Formulary.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2012/1916/schedule/13/paragraph/wrapper3n1",
    "retrieved_at": "2026-10-29T01:24:34.993203+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}